165 285

Cited 3 times in

Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia

DC Field Value Language
dc.contributor.author김경식-
dc.contributor.author윤미진-
dc.contributor.author이혜원-
dc.contributor.author한대훈-
dc.contributor.author김동우-
dc.date.accessioned2022-12-22T02:34:45Z-
dc.date.available2022-12-22T02:34:45Z-
dc.date.issued2022-07-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/191643-
dc.description.abstractHCC is well known for low glycolysis in the tumors, whereas hypoxia induces glycolytic phenotype and tumor progression. This study was conducted to evaluate the expression of SLCs in human HCCs and investigated whether extracellular nutrient administration related to SLCs in low-glycolytic HCC can prevent hypoxic tumor progression. SLCs expression was screened according to the level of glycolysis in HCCs. Then, whether extracellular nutrient treatment can affect hypoxic tumor progression, as well as the mechanisms, were evaluated in an in vitro cell line and an in vivo animal model. Low-glycolytic HCCs showed high SLC13A5/NaCT and SLC16A1/MCT1 but low SLC2A1/GLUT1 and HIF1α/HIF1α expression. Especially, high SLC13A5 expression was significantly associated with good overall survival in the Cancer Genome Atlas (TCGA) database. In HepG2 cells with the highest NaCT expression, extracellular citrate treatment upon hypoxia induced HIF1α degradation, which led to reduced glycolysis and cellular proliferation. Finally, in HepG2-animal models, the citrate-treated group showed smaller tumor with less hypoxic areas than the vehicle-treated group. In patients with HCC, SLC13A5/NaCT is an important SLC, which is associated with low glycolysis and good prognosis. Extracellular citrate treatment induced the failure of metabolic adaptation to hypoxia and tumor growth inhibition, which can be a potential therapeutic strategy in HCCs.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfCANCERS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleExtracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorSeon Yoo Kim-
dc.contributor.googleauthorDongwoo Kim-
dc.contributor.googleauthorJisu Kim-
dc.contributor.googleauthorHae Young Ko-
dc.contributor.googleauthorWon Jin Kim-
dc.contributor.googleauthorYoungjoo Park-
dc.contributor.googleauthorHye Won Lee-
dc.contributor.googleauthorDai Hoon Han-
dc.contributor.googleauthorKyung Sik Kim-
dc.contributor.googleauthorSunghyouk Park-
dc.contributor.googleauthorMisu Lee-
dc.contributor.googleauthorMijin Yun-
dc.identifier.doi10.3390/cancers14143355-
dc.contributor.localIdA00299-
dc.contributor.localIdA02550-
dc.contributor.localIdA03318-
dc.contributor.localIdA04273-
dc.relation.journalcodeJ03449-
dc.identifier.eissn2072-6694-
dc.identifier.pmid35884416-
dc.subject.keywordSLC13A5/NaCT-
dc.subject.keywordcancer metabolism-
dc.subject.keywordcitrate-
dc.subject.keywordhepatocellular carcinoma-
dc.subject.keywordhypoxia-
dc.contributor.alternativeNameKim, Kyung Sik-
dc.contributor.affiliatedAuthor김경식-
dc.contributor.affiliatedAuthor윤미진-
dc.contributor.affiliatedAuthor이혜원-
dc.contributor.affiliatedAuthor한대훈-
dc.citation.volume14-
dc.citation.number14-
dc.citation.startPage3355-
dc.identifier.bibliographicCitationCANCERS, Vol.14(14) : 3355, 2022-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.